Erythropoietic Protoporphyria
·MeSH: Protoporphyria, Erythropoietic
Prevalence
0.1 / 100K
2 drugs in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| bitopertin | Disc Medicine, Inc. (IRON) |
Phase 2(1)
| Drug | Company |
|---|---|
| disc-1459 | Disc Medicine, Inc. (IRON) |
Compare drugs
Frequently asked questions
How many drugs are in development for Erythropoietic Protoporphyria?
BioSniper tracks 2 drugs in development for Erythropoietic Protoporphyria across 1 company.
How many clinical trials target Erythropoietic Protoporphyria?
There are 2 clinical trials targeting Erythropoietic Protoporphyria tracked by BioSniper.
What is the prevalence of Erythropoietic Protoporphyria?
The estimated prevalence of Erythropoietic Protoporphyria is approximately 0.1 per 100,000 population.
Deep-dive into Erythropoietic Protoporphyria
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis